United States: Orange Is The New Black: FTC Targets Improper Patent Listings As Anticompetitive - Mintz

On September 14, with support from the FDA, the FTC issued a policy statement warning brand-name drug manufacturers that improper listing of patents in the FDA's "Approved Drug Products...